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Abstract  
Human respiratory syncytial virus (HRSV) is one of the most important causes of acute 
respiratory infections (ARI) in young children. HRSV diagnosis is based on the detection of 
the virus in respiratory specimens. Nasopharyngeal swabbing is considered the preferred 
method of sampling, although there is limited evidence of the superiority of nasopharyngeal 
swabs (NPS) over the less invasive nasal (NS) and throat (TS) swabs for virus detection by 
real-time quantitative RT-PCR (RT-qPCR). In the current study, we compared the three 
swabbing methods for the detection of HRSV by RT-qPCR in children hospitalized with 
ARI at Mahosot Hospital, Vientiane, Laos. In 2014, NS, NPS and TS were collected from 
288 children. All three samples were tested for HRSV by RT-qPCR; 141 patients were 
found positive for at least one sample. Almost perfect agreements (kappa>0.8) between the 
swabs, compared two by two, were observed. Detection rates for the three swabs (between 
93% and 95%) were not significantly different, regardless of the clinical presentation. Our 
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findings suggest that the uncomfortable and technically more demanding NPS method is not 
mandatory for HRSV detection by RT-qPCR. 
Introduction  
Human respiratory syncytial virus (HRSV) is a common respiratory pathogen in children 
under the age of five years. In 2015, there were estimated to be 33.1 million new episodes of 
HRSV-associated acute lower respiratory infections worldwide, of which 3.2 million were 
hospitalized and 59 600 patients died.1 HRSV diagnosis is based on the detection of the 
virus in respiratory specimens using cell culture, immunofluorescence, immuno-enzymatic 
or molecular assays. During the past decade, polymerase chain reaction (PCR), a fast and 
accurate detection tool, has been widely used in diagnosis and is often chosen over 
conventional methods for the detection of respiratory pathogens.2 
Collection of nasopharyngeal swabs (NPS) is considered the preferred sampling method for 
the detection of respiratory viruses,3 although it requires experienced staff and can be 
uncomfortable, especially for young children. There is limited evidence of the superiority of 
NPS over the less invasive nasal (NS) and throat (TS) swabs for virus detection by real-time 
PCR, with only a few studies evaluating HRSV detection in children 4–7 and two including 
NS.6,7 We are not aware of studies that have compared all three sampling methods. 
In 2014, we conducted a study on children (<5-years old) hospitalized at Mahosot Hospital, 
Vientiane, Laos, with acute respiratory infection (ARI).8 Three different samples (NS, TS 
and NPS) were collected from a large proportion of these patients. Since HRSV was one of 
the most common pathogens detected, this gave us the opportunity to compare the 
performance of these three sampling techniques for the detection of HRSV by real-time 
reverse transcription PCR (RT-qPCR). 
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Methods  
Specimen collection 
From December 2013 to December 2014, 383 children less than 5-years old, with a clinical 
presentation of ARI were enrolled, as previously described.8 At inclusion, samples were 
collected at the same time in the following sequence: TS, NS then NPS. They were 
available for 288 (75.2%) patients who were included in this study. NS and TS were placed 
separately in 1 mL viral transport medium (Sigma Virocult® (MWE)) vials. NPS was 
placed in 1 mL of skim-milk tryptone glucose glycerol medium (STGG), to allow 
subsequent bacterial and viral investigations from the same sample.9 Virocult vials and 
STGG were transported to the laboratory within 2 hours in a cool box. Swabs were 
squeezed, and the media were aliquoted and stored at -80°C before performing the 
laboratory assays.  
Testing for HRSV 
Nucleic acids were extracted from 100 µL of each swab medium using the Cador Pathogen 
96 QIAcube HT kit (Qiagen, Germany) following the manufacturer’s instructions, with an 
elution volume of 90 µL. RT-qPCR for HRSVA/B detection was performed using specific 
primers and probes as described by Bonroy et al.10 Testing was performed following the 
manufacturer’s instructions, using the EXPRESS One-Step Superscript™ qRT-PCR 
Universal Kit (Thermo Fisher Scientific, USA), 5 µL of RNA, 500 nM of each primer and 
200 nM of probe in a final reaction volume of 20 µL. The limit of detection of this HRSV 
RT-qPCR assay is 9.5 copies/µL, estimated using triplicates of 1/5 serial dilutions of 
quantified synthetic RNA. Amplification and detection were performed with the 
QuantStudio 12K Flex Real-time PCR system instrument (Applied Biosystems, USA). The 
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thermal cycling was: 15 minutes at 50°C, 2 minutes at 95°C, followed by 40 cycles of 15 
seconds at 95°C and 30 seconds at 60°C. Negative and positive controls were added to each 
run. Samples with Cq value <35 were considered as positive for HRSV. 
HRSV quantification  
RNA (4.93⋅106 copies/µL, quantified by RT-qPCR using a quantified synthetic RNA 
prepared as previously described11), was extracted from an HRSV A strain (UVE/HRSV-
A/2011/FR/3506, reference 001V-02477 provided by the EVA collection 
https://www.european-virus-archive.com/) and used as a positive control. Ten-fold serial 
dilutions of the RNA (1, 10-1, 10-2, 10-3, 10-4) were prepared, aliquoted and stored at -80°C 
to be used as standards. One aliquot of each standard was added to each RT-qPCR run, then 
the standard curve was drawn for the quantification of each tested sample. 
Statistical analysis 
Patients were classified as HRSV-positive if at least one of the three swabs were found 
positive by RT-qPCR. Detection rate was calculated for a given swab as the percentage of 
HRSV patients detected. Agreements of the HRSV RT-qPCR results between the swabs, 
compared two by two, were assessed by calculating the Kappa coefficient. The kappa results 
were interpreted as follows: values ≤0 as indicating no agreement and 0.01-0.20 as none to 
slight, 0.21-0.40 as fair, 0.41-0.60 as moderate, 0.61-0.80 as substantial, and 0.81-1.00 as 
almost perfect agreement 12. Calculation of 95% confidence intervals (CI) was performed 
using Statistical Package for the Social Sciences version 23.0 for Windows (SPSS Inc., 
Chicago, IL, USA). 
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
Ethics 
The study was conducted according to the protocol approved by the National Ethics 
Committee for Health Research, Ministry of Health, Lao PDR, and the Oxford Tropical 
Research Ethics Committee. Signed informed consent was obtained from the parents of 
each child included in this study. 
Results  
The median (IQR) age of the 288 patients included was 14 months (7-23 months); 165 
(57.3%) were male. The characteristics of the patients are presented in supplemental data 
(S1 Table). 
One hundred and forty-one (49.0%) patients were found positive for HRSV from at least 
one sample type. TS was positive in 131 (45.5%) patients, NS in 134 (46.5%) and NPS in 
132 (45.8%). Almost perfect agreements (kappa>0.80) between the three swabs, compared 
two by two, for HRSV RT-qPCR results were observed (Table 1). No significant difference 
was observed between the detection rates calculated for each specimen type: 92.9% 
(95%CI: 87.3-96.5) for TS, 95.0% (95%CI: 90.0-98.0) for NS and 93.6% (95%CI: 88.2-
97.0) for NPS (Figure 1 and Table 1, and supplemental data S1 Table). 
Detection rates of the three sampling techniques were analysed according to demographic 
and clinical patient characteristics along with their 95%CI (Figure 1 and Supplemental data 
S1 Table). No significant difference was observed between the three different swabs for any 
of the characteristics analysed, even after stratification by age, gender and clinical 
presentation (including with or without coryza). However, only seven HRSV positive 
patients presented with no coryza.  
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The median (IQR) of HRSV viral load detected was 1.3⋅107 copies/mL (2.3⋅106 - 9.3x107) 
in TS, 6.9⋅108 copies/mL (8.8⋅107 - 3.2⋅109) in NS, and 8.8⋅108 copies/mL (1.1⋅108 - 4.3⋅109) 
in NPS. HRSV viral load was on average significantly lower in TS than in NS and in NPS 
(p < 0.001, t test). When patients were sorted by increasing TS viral load, we observed that 
the viral load in TS was lower than in NS and NPS for most patients, 90% and 91% 
respectively (Figure 2).  
Discussion  
Although it is often considered a preferred method for the detection of respiratory 
pathogens, our study showed that NPS was not significantly better than NS or TS for the 
detection of HRSV by RT-qPCR in Lao children, with almost perfect agreements 
(kappa>0.80) between the swabs observed. The detection rates for the three swabs (between 
93% and 95%) were not significantly different. In addition, the HRSV viral load detected in 
NS was not significantly different to that in NPS (p > 0.05, t test) - but significantly higher 
than that in TS (p < 0.001, t test). 
Our findings are in accordance with previous publications. Grijalva et al.6 found good 
agreement between NS and NPS for the detection of HRSV. However, NPS were not 
systematically investigated for all patients and the study included only 36 HRSV patients. 
Dawood et al.7 observed high detection rates for both NS and TS (98% and 93% 
respectively) for the detection of 343 HRSV patients from 703 hospitalized children. 
However, they did not investigate NPS. 
We also investigated whether the choice of the sampling method should be based on 
particular patient characteristics, such as young age, specific respiratory symptoms, or signs 
of severity. For this, the detection rates of the three swabs were calculated and compared 
within different groups of patients sharing the same characteristics. No significant 
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difference was observed between the three different swabs for any of the patient groups 
tested. However, most of the patients included in this study had coryza (90%), so the values 
of detection rate for the three swabs could not be established with accuracy for the seven 
HRSV patients with no coryza.  
Accurate diagnosis is closely linked to the quality of the sample collection, which could be 
impacted, amongst other things, by the practicability of the sampling method and its 
acceptance by the patient and their family. Our study provides evidence that a simple and 
painless NS sampling can be used with a high degree of accuracy for the detection of HRSV 
by RT-qPCR in children hospitalized for ARI presenting with coryza. This is of particular 
importance, especially in young children for whom NPS sampling is unpleasant and can be 
challenging when performed by less experienced staff. When available, simple and painless 
methods should be prioritized after appropriate validation. However, our study was limited 
to the assessment of HRSV detection in children less than 5 years old, therefore 
extrapolation of our findings to other age groups and/or other respiratory viruses would 
require additional investigations.  
We conclude that performing NS sampling is appropriate for the molecular detection of 
HRSV in children under the age of 5 years. Further investigations are needed for systematic 
comparison of all swabbing methods in different clinical contexts and for an extended panel 
of respiratory pathogens.  
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Figures 
Figure 1. Detection rate of the three swabs tested for the detection of HRSV by 
RT-qPCR according to patient characteristics. Only the characteristics which were 
observed in more than 30 HRSV-positive patients are displayed.  #Detection rate of 
each swab for the detection of HRSV by RT-qPCR calculated over the total number of 
positive patients (positive in at least one of the three swabs tested). ●‘PCV13 
received’ if they had received at least two doses of vaccine for children less than 1-
year old or at least one dose of vaccine for children between 1 to 2-year old. *wet 
season: from May to October. ■Low birth weight: defined by World Health 
Organisation as weight at birth less than 2,500 g. ❖Fever: defined as body 
temperature ≥38°C per axilla. ➤HRSV positive patients=positive for HRSV by RT-
qPCR for at least one of the three swabs tested.  ♣Pneumonia and severe pneumonia 
were defined according to WHO criteria: children who presented with cough or 
difficulty breathing and had fast breathing (aged 2–11 months: ≥50 breaths/minute, 
aged 1–4 years: ≥40 breaths/minute) or chest indrawing, were classified as having 
pneumonia; children who presented with cough or difficulty breathing and had at least 
one of the following criteria were classified as severe pneumonia: oxygen saturation 
<90%, while breathing room air, or central cyanosis; severe respiratory distress; signs 
of pneumonia with a general danger sign (inability to breastfeed or drink, lethargy or 
reduced level of consciousness, convulsions, vomiting). Children <2 months old who 
presented with cough or difficulty breathing and fast breathing (≥60 breaths/min) were 
classified as severe pneumonia. 
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Figure 2. Comparison of HRSV viral loads detected in throat, nasal, and 
nasopharyngeal swabs for all patients tested. Patients are distributed along the x-axis, 
sorted by increasing HRSV viral load detected in throat swab. 
 
Table 1. Detection rates of the three swabs tested for the detection of HRSV by RT-qPCR. 
Character
istics 
All 
ARI 
patie
nts, n 
(%) 
HRS
V 
positi
ve*, n 
(%) 
TS NS NPS Kappa
⁋ 
(95%CI) 
HRS
V 
positi
ve, n 
(%) 
Det 
Rate#
, % 
(95%
CI) 
HRS
V 
positi
ve, n 
(%) 
Det 
Rate#
, % 
(95%
CI) 
HRS
V 
positi
ve, n 
(%) 
Det 
Rate#
,% 
(95%
CI) 
TS 
- 
NS 
TS 
- 
NP
S 
NS 
- 
NP
S 
Number 
of 
patients 
288 141 131 
92.9 
(87.3-
96.5) 
134 
95.0 
(90.0-
97.9) 
132 
93.6 
(88.2-
97.0) 
0.8
9 
(0.8
7-
0.9
1) 
0.8
9 
(0.8
6-
0.9
1) 
0.9
5 
(0.9
4-
0.9
6) 
Age 
(months), 
7 (14-
23) 
6 (13-
20) 
6 (13-
20)  
6 (13-
20)  
6 (13-
20)     
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median 
(IQR) 
Age 
groups            
< 1-year old 117 (40,6) 
66 
(46,8) 
60 
(45,8) 
90.9 
(81,2-
96.6) 
62 
(46,3) 
93,9 
(85,2-
98,3) 
61 
(46,2) 
92,4 
(83,2-
97,5) 
0.8
2 
(0.7
6-
0.8
7) 
0.8
5 
(0.7
8-
0.8
9) 
0.9
5 
(0.9
2-
0.9
6) 
1 to < 2-
years old 
100 
(34.7) 
54 
(38.3) 
51 
(38.9) 
94.4 
(84.6-
98.8) 
53 
(39.6) 
98.1 
(90.1-
100) 
52 
(39.4) 
96.3 
(87.3-
99.5) 
0.9
6 
(0.9
4-
0.9
7) 
0.9
4 
(0.9
1-
0.9
5) 
0.9
4 
(0.9
1-
0.9
5) 
2 to < 5-
years old 
71 
(24.7) 
21 
(14.9) 
20 
(15.3) 
95.2 
(76.2-
99.9) 
19 
(14.2) 
90.5 
(69.6-
98.8) 
19 
(14.4) 
90.5 
(69.6-
98.8) 
0.8
9 
(0.8
3-
0.9
3) 
0.8
9 
(0.8
3-
0.9
3) 
1.0
0 
Gender 
(male) 
165 
(57.3) 
83 
(58.9) 
77 
(58.9) 
92.8 
(84.9-
97.3) 
78 
(58.2) 
94.0 
(86.5-
98.2) 
77 
(58.3) 
92.8 
(84.9-
97.3) 
0.8
6 
(0.8
2-
0.9
0) 
0.8
7 
(0.8
3-
0.9
0) 
0.9
6 
(0.9
5-
0.9
7) 
*HRSV positive patients=positive for HRSV by RT-qPCR for at least one of the three swabs tested.  
#Det Rate= Detection rate of each swab for the detection of HRSV by RT-qPCR calculated over the 
number of patients positive in any of the three swabs.  
TS: throat swab, NS: nasal swab, NPS: nasopharyngeal swab.  
⁋Kappa coefficient measures agreement of the HRSV RT-qPCR results between the swabs, compared 
two by two.  
 
This article is protected by copyright. All rights reserved. 
